MyAverix Finance
F · Healthcare
VIRIDIAN THERAPEUTICS (1S1)
Biotechnology
VIRIDIAN THERAPEUTICS (1S1) is listed on F in the Healthcare sector. Industry: Biotechnology. As of 2026-03-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 1S1
VIRIDIAN THERAPEUTICS (1S1) — FAQ
What is 1S1's P/E ratio?
The price-to-earnings (P/E) ratio for VIRIDIAN THERAPEUTICS (1S1) is 18.00 (data as of 2026-03-23).
Does VIRIDIAN THERAPEUTICS pay a dividend?
Dividend yield is not available in the current snapshot for VIRIDIAN THERAPEUTICS (1S1). Check the MyAverix Finance app for the latest dividend data.
What sector is VIRIDIAN THERAPEUTICS in?
VIRIDIAN THERAPEUTICS (1S1) is classified in the Healthcare sector (Biotechnology industry).
What exchange is 1S1 listed on?
1S1 is listed on F.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.